Table 1 Sample characteristics
Participants N = 14 | Nonparticipants N = 16 | |
|---|---|---|
Age, median (IQR) | 48.5 (27–82) | 53 (26–81) |
Gender, n (%) | ||
Male | 4 (30) | 5 (31.3) |
Female | 9 (64) | 11 (68.8) |
Transgender | 1 (7) | 0 (0) |
Race, n (%) | ||
Hispanic | 4 (28.5) | 3 (18.7) |
Non-Hispanic White | 4 (28.5) | 10 (62.5) |
Non-Hispanic Black | 4 (28.5) | 3 (18.7) |
Non-Hispanic Other | 1 (7.1) | 0 (0) |
Prefer not to answer | 1 (7.1) | 0 (0) |
Employed, n (%) | ||
Yes | 5 (36) | 6 (37.5) |
No | 9 (64) | 10 (62.5) |
Education, n (%) | ||
< 12 years | 2 (14) | 3 (18.8) |
≥ 12 years | 12 (86) | 13 (81.3) |
Tobacco smoking, n (%) | ||
Yes | 2 (14) | 4 (25) |
No | 12 (86) | 12 (75) |
Using opioids, n (%) | ||
Yes | 5 (36) | 10 (62.5) |
No | 9 (64) | 6 (37.5) |
Medical cannabis use frequency, n (%)* | ||
Infrequent use | 4 (28) | 2 (12.5) |
Occasional use | 5 (36) | 6 (37.5) |
Frequent use | 5 (36) | 8 (50) |
Pain location | ||
≥ 4 body sites | 9 (64) | 8 (50) |
Head/neck | 7 (50) | 9 (56.3) |
Arm/elbow/hand | 6 (43) | 8 (50) |
Shoulder | 7 (50) | 7 (43.8) |
Back | 11 (79) | 13 (81.3) |
Knee | 10 (71) | 7 (43.8) |
Leg | 8 (57) | 8 (50) |
Pain intensity and interference (PEG-3), median (IQR) | 7.66 (0–9.66) | |
Insomniaa, n (%) | ||
No clinically significant insomnia | 5 (36) | 5 (31.3) |
Subthreshold insomnia | 4 (29) | (37.5) |
Clinical insomnia (moderate severity) | 3 (21) | 3 (18.8) |
Clinical insomnia (severe) | 2 (14) | 2 (12.5) |
Anxietyb, n (%) | ||
Minimal anxiety | 7 (50) | 7 (43.8) |
Mild anxiety | 3 (21) | 3 (18.8) |
Moderate anxiety | 0 (0) | 4 (25) |
Severe anxiety | 4 (29) | 2 (12.5) |
Depressionc, n (%) | ||
Minimal depression | 5 (36) | 3 (18.8) |
Mild depression | 3 (21) | 5 (31.3) |
Moderate depression | 2 (14) | 3 (18.8) |
Moderately severe depression | 4 (29) | 4 (25) |
Severe depression | 0 (0) | 1 (6.3) |